Results 71 to 80 of about 69,664 (311)

Effect of furosemide in the treatment of high-altitude pulmonary edema

BMC Pulmonary Medicine
Background High-altitude pulmonary edema (HAPE) refers to the onset of breathlessness, cough, and fever at rest after arriving at high altitudes. It is a life-threatening illness caused by rapid ascent to high altitudes.
Dava Tenzing, Pianduo Suolang, Deji Gesang, Duoji Suolang, Gaozhan Duan, Wangmu Ciren, Yihui Wang, Tongtian Ni   +7 more
doaj   +1 more source

Effect of Inhaled Nebulized Furosemide (40 and 120 mg) on Breathlessness during Exercise in the Presence of External Thoracic Restriction in Healthy Men

Frontiers in Physiology, 2018
Inhalation of nebulized furosemide has been shown to alleviate breathlessness provoked experimentally in health and disease; however, it remains unclear whether the efficacy of nebulized furosemide on breathlessness is dose-dependent.
Marcus Waskiw-Ford, Anne Wu, Amar Mainra, Noah Marchand, Abdullatif Alhuzaim, Jean Bourbeau, Jean Bourbeau, Jean Bourbeau, Jean Bourbeau, Jean Bourbeau, Jean Bourbeau, Benjamin M. Smith, Benjamin M. Smith, Benjamin M. Smith, Benjamin M. Smith, Benjamin M. Smith, Benjamin M. Smith, Dennis Jensen, Dennis Jensen, Dennis Jensen, Dennis Jensen, Dennis Jensen, Dennis Jensen   +22 more
doaj   +1 more source

Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left‐sided congestive heart failure in dogs

Journal of Veterinary Internal Medicine, 2022
Background Kidney injury (KI) has been documented in dogs treated with furosemide for left‐sided congestive heart failure (CHF). Hypothesis/Objectives Determine risk factors for development of KI in furosemide‐treated dogs and determine the effect of KI ...
Maria E. Giorgi, Jonathan P. Mochel, Lingnan Yuan, Darcy B. Adin, Jessica L. Ward   +4 more
doaj   +1 more source

Dermatologic adverse effect of subcutaneous furosemide administration in a cat

Open Veterinary Journal, 2023
Background: Furosemide is a mainstay of treatment in congestive heart failure (CHF) and is widely prescribed to dogs and cats by several formulations, including the subcutaneous one.
Chiara Mazzoldi, Francesca Aspidi, Giovanni Romito   +2 more
doaj   +1 more source

Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system. [PDF]

, 2015
Interactions between sodium and calcium regulating systems are poorly characterized but clinically important. Parathyroid hormone (PTH) levels are increased shortly after furosemide treatment by an unknown mechanism, and this effect is blunted by the ...
Anex, C., Bonny, O., Burnier, M., Forni Ogna, V., Maillard, M., Muller, M.E., Stoudmann, C., Wuerzner, G., Zweiacker, C.   +8 more
core   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study

BMC Cancer, 2019
Background Pre-clinical studies have shown that furosemide slows cancer cell growth by acting on the Na-K-2Cl transporter, particularly for gastric cancer cells.
Peipei Liu, Úna C. McMenamin, Andrew D. Spence, Brian T. Johnston, Helen G. Coleman, Chris R. Cardwell   +5 more
doaj   +1 more source

BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide

Pharmaceutics, 2020
Biopharmaceutical classification system (BCS) class IV drugs (low-solubility low-permeability) are generally poor drug candidates, yet, ~5% of oral drugs on the market belong to this class.
Milica Markovic, Moran Zur, Inna Ragatsky, Sandra Cvijić, Arik Dahan   +4 more
doaj   +1 more source

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy

Journal of Veterinary Internal Medicine, 2022
Background Activity of the circulating renin‐angiotensin‐aldosterone system (RAAS) has not been comprehensively characterized in cats with systemic hypertension (SH) or cardiomyopathy (CM), and the effects of furosemide or amlodipine treatment on the ...
Jessica L. Ward, Emilie Guillot, Oliver Domenig, Wendy A. Ware, Lingnan Yuan, Jonathan P. Mochel   +5 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source